Literature DB >> 16091917

Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection.

Davood Mansouri1, Parisa Adimi, Mehdi Mirsaeidi, Nahal Mansouri, Soheila Khalilzadeh, Mohammad R Masjedi, Parvaneh Adimi, Payam Tabarsi, Mohammad Naderi, Orchidée Filipe-Santos, Guillaume Vogt, Ludovic de Beaucoudrey, Jacinta Bustamante, Ariane Chapgier, Jacqueline Feinberg, Ali A Velayati, Jean-Laurent Casanova.   

Abstract

Disseminated BCG infection is a rare complication of vaccination that occurs in patients with impaired immunity. In recent years, a series of inherited disorders of the IL-12-IFN-gamma axis have been described that predispose affected individuals to disseminated disease caused by BCG, environmental Mycobacteria, and non-typhoidal Salmonella. The routine immunological work-up of these patients is normal and the diagnosis requires specific investigation of the IL-12-IFN-gamma circuit. We report here the first two such patients originating from and living in Iran. The first child is two years old and suffers from complete IFN-gamma receptor 2 deficiency and disseminated BCG infection. He is currently in clinical remission thanks to prolonged multiple antibiotic therapy. The other, a 28-year-old adult, suffers from IL-12p40 deficiency and presented with disseminated BCG infection followed by recurrent episodes of systemic salmonellosis. He is now doing well. A third patient of Iranian descent, living in North America, was reported elsewhere to suffer from IL-12Rbeta1 deficiency. These three patients thus indicate that various inherited defects of the IL-12-IFN-gamma circuit can be found in Iranian people. In conclusion we recommend to consider the disorders of the IL-12-IFN-gamma circuit in all patients with severe BCG infection, disseminated environmental mycobacterial disease, or systemic non-typhoidal salmonellosis, regardless of their ethnic origin and country of residence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091917     DOI: 10.1007/s00431-005-1689-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  29 in total

1.  Salmonella empyema in a patient with lymphoma.

Authors:  P A Cistulli; D J Barnes; G A Young
Journal:  Aust N Z J Med       Date:  1991-04

2.  A malignant pleural effusion infected with Salmonella enteritidis.

Authors:  G V Gill; A Holden
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

Review 3.  Disseminated bacille Calmette-Guérin disease after vaccination: case report and review.

Authors:  E A Talbot; M D Perkins; S F Silva; R Frothingham
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

4.  IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18.

Authors:  U Müller; G Köhler; H Mossmann; G A Schaub; G Alber; J P Di Santo; F Brombacher; C Hölscher
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

5.  Pleural empyema due to Salmonella paratyphi in a patient with AIDS.

Authors:  D Wolday; B Seyoum
Journal:  Trop Med Int Health       Date:  1997-12       Impact factor: 2.622

6.  Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans.

Authors:  Calman MacLennan; Claire Fieschi; David A Lammas; Capucine Picard; Susan E Dorman; Ozden Sanal; Jenny M MacLennan; Steven M Holland; Tom H M Ottenhoff; Jean-Laurent Casanova; Dinakantha S Kumararatne
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

7.  Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency.

Authors:  Isabel Caragol; Miquel Raspall; Claire Fieschi; Jaqueline Feinberg; María N Larrosa; Manuel Hernández; Concepción Figueras; Jose-María Bertrán; Jean-Laurent Casanova; Teresa Español
Journal:  Clin Infect Dis       Date:  2003-07-07       Impact factor: 9.079

8.  Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection.

Authors:  F Altare; D Lammas; P Revy; E Jouanguy; R Döffinger; S Lamhamedi; P Drysdale; D Scheel-Toellner; J Girdlestone; P Darbyshire; M Wadhwa; H Dockrell; M Salmon; A Fischer; A Durandy; J L Casanova; D S Kumararatne
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

9.  Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor beta 1 deficiency.

Authors:  Aileen M Cleary; Wenwei Tu; Andrea Enright; Thierry Giffon; Rene Dewaal-Malefyt; Kathleen Gutierrez; David B Lewis
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

Review 10.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

View more
  20 in total

1.  Endogenously activated interleukin-4 differentiates disease progressors and non-progressors in tuberculosis susceptible families: a 2-year biomarkers follow-up study.

Authors:  Rabia Hussain; Najeeha Talat; Ambreen Ansari; Firdaus Shahid; Zahra Hasan; Ghaffar Dawood
Journal:  J Clin Immunol       Date:  2011-07-14       Impact factor: 8.317

2.  Personalized medicine approach in mycobacterial disease.

Authors:  Mehdi Mirsaeidi
Journal:  Int J Mycobacteriol       Date:  2012-06

Review 3.  Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases.

Authors:  Sayna Norouzi; Asghar Aghamohammadi; Setareh Mamishi; Sergio D Rosenzweig; Nima Rezaei
Journal:  J Infect       Date:  2012-03-16       Impact factor: 6.072

Review 4.  Innate defects of the IL-12/IFN-γ axis in susceptibility to infections by mycobacteria and salmonella.

Authors:  Noé Ramirez-Alejo; Leopoldo Santos-Argumedo
Journal:  J Interferon Cytokine Res       Date:  2013-12-20       Impact factor: 2.607

Review 5.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

6.  Frequency of Mycobacterium bovis and mycobacteria in primary immunodeficiencies.

Authors:  Ezgi Ulusoy; Neslihan Edeer Karaca; Güzide Aksu; Cengiz Çavuşoğlu; Necil Kütükçüler
Journal:  Turk Pediatri Ars       Date:  2017-09-01

7.  Analysis of the interleukin-12/interferon-gamma pathway in children with non-tuberculous mycobacterial cervical lymphadenitis.

Authors:  Francis Serour; Avraham Mizrahi; Eli Somekh; Jacqueline Feinberg; Capucine Picard; Jean-Laurent Casanova; Ilan Dalal
Journal:  Eur J Pediatr       Date:  2006-11-21       Impact factor: 3.183

8.  Autosomal Dominant IFN-γR1 Deficiency Presenting with both Atypical Mycobacteriosis and Tuberculosis in a BCG-Vaccinated South African Patient.

Authors:  Brigitte Glanzmann; Marlo Möller; Marcela Moncada-Velez; Jonny Peter; Michael Urban; Paul D van Helden; Eileen G Hoal; Nikola de Villiers; Richard H Glashoff; Rina Nortje; Jacinta Bustamante; Laurent Abel; Jean-Laurent Casanova; Stephanie Boisson-Dupuis; Monika Esser; Craig J Kinnear
Journal:  J Clin Immunol       Date:  2018-05-18       Impact factor: 8.317

9.  Mendelian Susceptibility to Mycobacterial Disease Caused by a Novel Founder IL12B Mutation in Saudi Arabia.

Authors:  Abdulrahman N Alodayani; Abdulnasir M Al-Otaibi; Caroline Deswarte; Husn Habib Frayha; Matthieu Bouaziz; Maryam AlHelale; Tom Le Voyer; Alejandro Nieto-Patlan; Vimel Rattina; Mofareh AlZahrani; Rabih Halwani; Fahad Al Sohime; Hamoud Al-Mousa; Saleh Al-Muhsen; Sami H Alhajjar; Nabil S Dhayhi; Laurent Abel; Jean-Laurent Casanova; Ibrahim Bin-Hussain; May S AlBarrak; Suliman A Al-Jumaah; Jacinta Bustamante
Journal:  J Clin Immunol       Date:  2018-03-27       Impact factor: 8.317

10.  Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis.

Authors:  Hassan Abolhassani; Fatemeh Kiaee; Marzieh Tavakol; Zahra Chavoshzadeh; Seyed Alireza Mahdaviani; Tooba Momen; Reza Yazdani; Gholamreza Azizi; Sima Habibi; Mohammad Gharagozlou; Masoud Movahedi; Amir Ali Hamidieh; Nasrin Behniafard; Mohammamd Nabavi; Mohammad Hassan Bemanian; Saba Arshi; Rasol Molatefi; Roya Sherkat; Afshin Shirkani; Reza Amin; Soheila Aleyasin; Reza Faridhosseini; Farahzad Jabbari-Azad; Iraj Mohammadzadeh; Javad Ghaffari; Alireza Shafiei; Arash Kalantari; Mahboubeh Mansouri; Mehrnaz Mesdaghi; Delara Babaie; Hamid Ahanchian; Maryam Khoshkhui; Habib Soheili; Mohammad Hossein Eslamian; Taher Cheraghi; Abbas Dabbaghzadeh; Mahmoud Tavassoli; Rasoul Nasiri Kalmarzi; Seyed Hamidreza Mortazavi; Sara Kashef; Hossein Esmaeilzadeh; Javad Tafaroji; Abbas Khalili; Fariborz Zandieh; Mahnaz Sadeghi-Shabestari; Sepideh Darougar; Fatemeh Behmanesh; Hedayat Akbari; Mohammadreza Zandkarimi; Farhad Abolnezhadian; Abbas Fayezi; Mojgan Moghtaderi; Akefeh Ahmadiafshar; Behzad Shakerian; Vahid Sajedi; Behrang Taghvaei; Mojgan Safari; Marzieh Heidarzadeh; Babak Ghalebaghi; Seyed Mohammad Fathi; Behzad Darabi; Saeed Bazregari; Nasrin Bazargan; Morteza Fallahpour; Alireza Khayatzadeh; Naser Javahertrash; Bahram Bashardoust; Mohammadali Zamani; Azam Mohsenzadeh; Sarehsadat Ebrahimi; Samin Sharafian; Ahmad Vosughimotlagh; Mitra Tafakoridelbari; Maziar Rahimi; Parisa Ashournia; Anahita Razaghian; Arezou Rezaei; Setareh Mamishi; Nima Parvaneh; Nima Rezaei; Lennart Hammarström; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2018-10-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.